Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-082-4 | CAS number: -
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
ABSORPTION
Based on physicochemical considerations (log Pow, water solubility), uptake of the substance from the gastrointestinal tract may occur after ingestion. Experimental data indicate that the extent of this absorption will be inversely related to carbon number, with negligible uptake for C29 and above. Applying this information to the proportions of i-alkane and n-alkane species present in the substance leads to a calculated gastrointestinal uptake of approximately 60%.
Based on physicochemical considerations (log Pow, water solubility), uptake of the substance across skin will be low.
Based on physicochemical considerations (log Pow, water solubility), uptake of the substance by the lung may occur following inhalation exposure. Experimental results indicate that tissue concentrations of three i-alkanes (C8, C9, C10) increased with increasing carbon number in rats exposed by inhalation (greatest for C10). Taken together this information supports potential uptake of the alkane species present in the substance vapour by the lung.
DISTRIBUTION
Experimental data demonstrate systemic distribution of C8, C9 and C10 i-alkanes in the rat following inhalation exposure, with internal concentrations being greatest in fat and lowest in blood (relative tissue concentrations: fat>>kidney, brain, liver>>blood). The results suggest that i-alkane components present in the substance will also be distributed within the body after inhalation exposure.
METABOLISM
Michaelis-Menten constants (Km, Vmax) for a series of C6-C10 iso- and normal alkanes were generally greater for n-alkanes relative to the corresponding i-alkanes when determined in vitro using a rat liver slice head-space technique. Other data indicate that metabolic clearance by rat liver microsomes (as predicted by Vmax) was inversely related to carbon number as follows: C9>C10>>>C14 (no detectable removal of n-tetradecane under the conditions of the study). By analogy, the C9 to C18 i-alkane species that predominate in the substance (accounting for greater than approx. 80% of the total) are expected to undergo negligible hepatic metabolism.
EXCRETION
Experimental data demonstrate removal of C8, C9 and C10 i-alkanes from rat kidney, brain, liver and blood 12 hours after inhalation exposure ceased, with detectable (but greatly reduced) levels present in fat only.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
